These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 36671381)

  • 1. Update on the Discovery of Efflux Pump Inhibitors against Critical Priority Gram-Negative Bacteria.
    Compagne N; Vieira Da Cruz A; Müller RT; Hartkoorn RC; Flipo M; Pos KM
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds.
    Schuster S; Vavra M; Wirth DAN; Kern WV
    Microbiol Spectr; 2024 Feb; 12(2):e0304523. PubMed ID: 38170977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances toward a molecular mechanism of efflux pump inhibition.
    Opperman TJ; Nguyen ST
    Front Microbiol; 2015; 6():421. PubMed ID: 25999939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial Characteristics of the Efflux Pump MexB Determine Inhibitor Binding.
    Yamasaki S; Koga N; Zwama M; Sakurai K; Nakashima R; Yamaguchi A; Nishino K
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0067222. PubMed ID: 36300935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from
    Alenazy R
    Biology (Basel); 2022 Sep; 11(9):. PubMed ID: 36138807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
    Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
    mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.
    Abdali N; Parks JM; Haynes KM; Chaney JL; Green AT; Wolloscheck D; Walker JK; Rybenkov VV; Baudry J; Smith JC; Zgurskaya HI
    ACS Infect Dis; 2017 Jan; 3(1):89-98. PubMed ID: 27768847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Art of War with
    Avakh A; Grant GD; Cheesman MJ; Kalkundri T; Hall S
    Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627724
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitors of multidrug resistant efflux systems in bacteria.
    Zechini B; Versace I
    Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):37-50. PubMed ID: 19149695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa.
    Askoura M; Mottawea W; Abujamel T; Taher I
    Libyan J Med; 2011 May; 6():. PubMed ID: 21594004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance.
    Wang Y; Mowla R; Guo L; Ogunniyi AD; Rahman T; De Barros Lopes MA; Ma S; Venter H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):733-739. PubMed ID: 28129976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps.
    Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Giovannelli L; Dei S; Teodori E
    J Antimicrob Chemother; 2022 Feb; 77(2):413-424. PubMed ID: 34747445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efflux-mediated antibiotics resistance in bacteria].
    Cattoir V
    Pathol Biol (Paris); 2004 Dec; 52(10):607-16. PubMed ID: 15596311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial efflux pump inhibitors from natural sources.
    Stavri M; Piddock LJ; Gibbons S
    J Antimicrob Chemother; 2007 Jun; 59(6):1247-60. PubMed ID: 17145734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic Potentiation Through Phytochemical-Based Efflux Pump Inhibitors to Combat Multidrug Resistance Bacteria.
    Cheema HS; Maurya A; Kumar S; Pandey VK; Singh RM
    Med Chem; 2023 Oct; ():. PubMed ID: 37907487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Microbe-Derived Efflux Pump Inhibitor of the Resistance-Nodulation-Cell Division Protein Restores Antibiotic Susceptibility in
    Tambat R; Mahey N; Chandal N; Verma DK; Jangra M; Thakur KG; Nandanwar H
    ACS Infect Dis; 2022 Feb; 8(2):255-270. PubMed ID: 35045260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AcrB efflux pump: conformational cycling and peristalsis lead to multidrug resistance.
    Seeger MA; Diederichs K; Eicher T; Brandstätter L; Schiefner A; Verrey F; Pos KM
    Curr Drug Targets; 2008 Sep; 9(9):729-49. PubMed ID: 18781920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
    Wang-Kan X; Rodríguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.
    Mowla R; Wang Y; Ma S; Venter H
    Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.